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Abstract
Objectives: To study the relation between host transcriptomic and DNA methylation changes in
periodontally diseased versus healthy gingival tissues. Materials and Methods: Gingival tissues from 20
chronic periodontitis patients were collected during osseous surgery from diseased and healthy sites.
Samples were homogenized and split into two aliquots: One aliquot for RNA sequencing and one for DNA
methylation analysis. Results: Periodontal findings: PD averaged 5.5 mm in disease sites vs. 2.7 mm in
control sites (p<0.001), clinical attachment level in disease was 5.8 mm vs. 3.1 mm in control (p<0.001).
RNA sequencing data: 20 genes were found to be upregulated, and 9 genes were down regulated between
similarly performing sample-pairs in pairwise comparison. Methylation data: Within the common
differentially expressed genes, 4 genes were overexpressed and hypomethylated. These genes were
TIGIT, MS4A1, ICOS and CD22. Further analysis of these genes revealed that they all participate in B-cell
or T-cell regulation. Functional analysis: Functional analysis was carried out by IPA which showed that
Th2 and T-cell receptor signaling pathways were mostly affected by differentially expressed genes.
Moreover, stratified analysis on demography showed African-American had a propensity to show similar
trends in terms of differential expression of genes and differential DNA methylation when compared to
the Caucasian. Conclusions: Epigenome Wide Association Studies of gingival tissues transcriptome and
methylome are useful for screening for biomarker candidates for chronic periodontitis. TIGIT, MS4A1,
ICOS and CD22 genes are potential candidate biomarkers for chronic periodontitis. Further validation of
these biomarkers using in vivo functional studies is necessary.
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Abstract
Objectives: To study the relation between host transcriptomic and DNA methylation changes in
periodontally diseased versus healthy gingival tissues. Materials and Methods: Gingival tissue
samples from 20 chronic periodontitis patients were collected during flap elevation of osseous
surgery from diseased sites, and at the same time, healthy tissues were also harvested. Samples
were homogenized and split into two aliquots. One aliquot for RNA sequencing and the second
aliquot was prepared for DNA methylation analysis. Results: Periodontal findings: Pocket Depth
(PD) was on average 5.5 mm in disease sites vs. 2.7 mm in control sites (p<0.001), Clinical
Attachment Loss (CAL) in disease was 5.8 mm vs. 3.1 mm in control (p<0.001). RNA
sequencing data: 20 genes were found to be upregulated, and 9 genes were down regulated
between similarly performing sample-pairs in pairwise comparisons. Methylation data: Within
the common differentially expressed genes, 4 genes were overexpressed and found to be
hypomethylated. These were T-cell Immunoreceptor with Immunoglobulin and ITIM domains
(TIGIT), Membrane-Spanning 4 Domains, Subfamily A, Member 1 (MS4A1), Inducible T-cell
Co-Stimulator (ICOS) and Cluster of Differentiation 22 (CD22) genes. Further analysis of these
genes revealed that all 4 genes participate in B-cell or T-cell regulation. Functional analysis:
Functional analysis was carried out by Ingenuity Pathway Analysis (IPA) which showed that
Th2 and T-cell receptor signaling pathways were mostly affected by differentially expressed
genes. Moreover, stratified analysis on demography showed African-American had a propensity
to show similar trends in terms of differential expression of genes and differential DNA
methylation when compared to the Caucasian population. Conclusions: Epigenome Wide
Association Studies (EWAS) of gingival tissues transcriptome and methylome are useful for
screening for biomarker candidates for chronic periodontitis. TIGIT, MS4A1, ICOS and CD22

genes are potential candidate biomarkers for chronic periodontitis. Further validation of these
biomarkers using in vivo functional studies is necessary. Taken together, our analysis of healthy
and disease tissue from the same patient potentiates the necessity for a personalized
pharmacogenetic approach in the diagnosis and treatment of periodontitis patients.

Introduction
Periodontitis is a chronic inflammatory disease of the tissues supporting the teeth. It is initiated
by bacteria that colonize the gingival crevice and teeth surface, followed by the host immune
response and results in gingival inflammation and the destruction of teeth supporting structures
(Kenneth, 2008). If left untreated it could result in tooth loss and other systemic complications
(Oppermann, 2012) (Helal, 2019). According to the National Health and Nutrition Examination
(NHNE) Survey, 2009-2014, 42% of United States >30 years old adults have periodontitis, and
7.8% have severe periodontitis (Eke, 2018)
Bacterial plaque is considered the primary etiological factor of periodontal disease (Nunn, 2003).
Some bacterial complexes are related to worse clinical findings and some with better (Socransky
SS, 1998). The host immune response to the bacterial insult determines disease progression,
extent, and resolution (Kenneth, 2008). Environmental factors such as smoking and diabetes
influence disease progression as well (Sonnenschein, 2015; Tonetti, Cigarette Smoking and
Periodontal Disease: Etiology and Management of Disease, 1998).
Genes play a role in the predisposition to and progression of periodontal diseases (Kinane, 2005).
In some cases, a specific genetic mutation will be responsible for the disease, for example, Ehler
Danlos Syndrome Type VIII is caused by a pathognomonic variant in gene 12q13 and will
manifest in early onset periodontitis (Rahman, 2003). In other cases, the genetic component
contributing to periodontal disease is multifactorial. Multifactorial inheritance of periodontal
disease is when the combined effect of multiple genes and environmental factors increase the
risk of periodontitis.
DNA methylation and Histone modifications are environmentally occurring inheritable chemical
modifications that effects gene expressions without changing the DNA sequence. Therefore, it is

postulated that DNA methylation and histone modifications will influence gene expression and
host responses in periodontal disease.

Periodontitis
All external body surfaces host a huge range of microorganisms. The mouth and gut are cavities
that are open to the external environment, therefore also harbor complex and rich
microorganisms, mainly bacteria. Commensal bacteria protect the host by adhering to the tissue
surfaces, hence preventing pathologic bacteria from growing, and creates an environment that
promotes the development of healthy periodontal tissue structure and function. In clinically
healthy periodontium, there is continuous leukocyte infiltration into the gingival tissue in
response to basal microbial presence. Meaning, in a healthy state there is always a low level of
controlled inflammation that does not propagate to disease (Meyle, 2015).

If a biofilm is left undisrupted and allowed to accumulate, the condition within it starts to favor
bacterial species such as fusobacterium nucleatum that are capable of sensing and reacting with
their surroundings, for example by quorum sensing (Meyle, 2015). The bacteria produce antigens
such as lipopolysaccharides (LPS), extracellular adenosine triphosphate (ATP), and extracellular
DNA, etc. The host respond by inflammation, which is characterized by releasing of proinflammatory cytokines, chemokines, and antimicrobial peptides, antibodies aid in the
recruitment of polymorphonuclear cells (PMNs), and later triggers acquired immunity (B and T
cells) and increased supply of certain nutrients, such as heme. Heme encourages the proliferation
of other pathogens such as Porphyromonas gingivalis (Mysak, 2014). This is the incipient
disease of gingivitis and in a non-susceptible individual, does not progress.
In the disease susceptible subject, the incipient lesion can trigger an excessive host immune
response, meaning, too much reaction with an excessive amount of cytokines, reactive oxygen
species (ROS), matrix-metalloproteinases, auto-antibodies, all of which eventually cause

oxidative stress and tissue damage (Darveau, 2010). The release of histamine and the activation
of complement components C3a and C5a lead to vasodilation, increase vascular permeability,
and slowing of blood flow within the respective capillary beds, allowing for an increased amount
of serum to move into the tissue. The serum becomes tissue fluid that carries inflammatory
peptides to the infected site while causing swelling and increased exudation of gingival
crevicular fluid (GCF). The pathogens benefit from this abundance of nutrients and some of
them can prolong the inflammatory response to their benefit (for example, activation of
complement by P. gingivalis) Plasma cells and neutrophils dominate the active inflammatory
lesion due to chemokine dominant niche. In these lesions, neutrophils appear to be particularly
destructive in their behavior because of dysregulation of chemotactic and microbial processes
and failure to release pro-resolvin lipid mediators such as lipoxins. Excessive or lacking
recruitment, or defective neutrophils are known to cause severe periodontitis (Meyle, 2015).
Taken together, when tissue damage occurs, specific molecular peptides are released which
further propagate the inflammatory response that causes further tissue damage creating a chronic
inflammatory lesion.

The body has means to limit and can modulate inflammation, for example, the release of
glucocorticoids, TGF-b, resolvin and protectin molecules. The first phase of the resolution is the
cessation of pro-inflammatory cell recruitment and their clearance by recirculation or
phagocytosis by macrophages. Additionally, stromal tissue cells must revert to the noninflammatory phenotype in the resolution phase (Serhan, 2007). On the other hand, if the body is
not successful in the resolution of inflammation, the attempted healing by angiogenesis and
fibrosis could create a rich nutritional environment sustaining the dysbiosis and thus the

increasing biofilm formation. This is called dysbiosis and is manifested by chronic inflammation,
a.e - chronic periodontitis (Van-Dyke, 2008). If the body was unsuccessful in the resolution of
the lesion, intervention is required to remove the biofilm and allow for the health-promoting
microbial species to re-establish. Then pro-resolution sequelae should ensue, reduction of the
inflammatory process, restoration of normal tissue structure and function (Van-Dyke, 2008).

Local, systemic, and environmental factors can contribute to the body’s inability to resolve
inflammation of the periodontal tissues. Local factors that allow for bacterial plaque
accumulation and inhibit efficient oral hygiene are, for example, teeth mal-alignment, crowding,
ill-fitting restorations or splinted teeth or restorations. Systemic and environmental factors that
influence the host response are largely varied, some of them can be modulated and altered and
some of them cannot (Van-Dyke, 2005). A non-modifiable inherent factor that affects
periodontal disease is the patients’ make-over building blocks – their genome.

Genetics
A genome is the inherited material that contains all the information needed to build the organism
and allow it to grow and develop. There is a big body of evidence and publications about the
hereditability of periodontal disease and the role of genes in the disease. The effect of genetics
on this disease is extremely varied and involves multiple systems and levels that are only
partially known to us as of now.

Specific mutations
In some cases, a specific genetic mutation will be responsible for the disease. These genetic
mutations are so disruptive, that their presence is predictably associated with disease and there is
no redundancy or compensation allowing the body to overcome the harmful effect. Some of the
genetically inherited diseases that are associated with periodontitis are Papillon-Lefevre,
Chediak-Higashi Syndrome, and Cyclic and Chronic Neutropenia (Hodge, 2001).
Ehler Danlos Syndrome Type VIII, for example, is caused by a pathognomonic variant in gene
12q13 and will manifest in early onset periodontitis and very thin if any keratinized attached
gingiva (Rahman, 2003) as well as non-dental manifestations. The inheritance of this mutation is
expressed in an autosomal dominant fashion, meaning that the presence of the mutation is in
direct correlation to the presence of the disease.

Multifactorial inheritance
Multifactorial inheritance of periodontal disease is when the combined effect of multiple genes
and environmental factors increase the risk of disease. The presence of one of the
pathognomonic alleles alone cannot be correlated 100% to disease occurrence, the
pathognomonic allele can be found in healthy individuals, but the presence of a few
pathognomonic alleles together was found to be statistically related to disease occurrence. These
genetic variations are also called polymorphism and are not considered pathognomonic
mutations by themselves, they are disease associated and can be found in high prevalence in the
population (Kinane, 2005).
A good explanation for this behavior of genes is the following: Physiologic and biologic
pathways tend to have redundancy and compensatory pathways. Therefore, unless a specific

mutation in a critical point of a pathway had occurred, a certain threshold of multiple pathogenic
alleles and environmental conditions can push an individual beyond the threshold to a disease
state. Therefore, multifactorial inheritance is much more difficult to diagnose or predict.
Epigenetic modifications
Epigenetics are the interface between genetics and environmental factors; Environmental factors
cause alterations in epigenetics and hence alter gene expression associated with inflammation
and susceptibility for inflammation related diseases. Epigenetic modifications are inherited and
stable but can also change during the life span due to environmental changes (Soubry, 2014).
Therefore, epigenetic modifications allow for the inheritance of environmentally influenced
modifications as described by Lacal et. al (Lacal, 2018).

Epigenetic modifications are created by a variety of molecules that connect to the DNA in
different areas and affect the way the DNA is being used. These can connect to different areas of
the DNA before within or after the open reading frame, see Figure-1.

Figure-1 – Eukaryote gene. The eukaryote gene is composed of multiple regulatory components,
some are pre-transcriptional like the promoter, and some are post transcriptional like the
untranslated regions (UTRs). The part of the gene that encodes for protein amino acids is only
the red part within the open reading frame (ORF). Courtesy of: Thomas Shafee, Wikimedia
Commons, CC-BY-4.0

Epigenetic modifications are produced by a variety of molecules that connect to the DNA and
alter the way the DNA is receptible for reading. Binding of activators and repressors to these
multiple regulatory sequences has a combined-cumulative effect on the rate of transcription.

We will now focus on two examples of epigenetic modifications – DNA methylation and histone
modification.

DNA methylation

DNA methylation is the addition of a methyl group on a DNA cytosine or adenine base. It affects
the transcription of the DNA without changing its sequence. DNA methylation is most common
on cytosine in a CpG dinucleotide sequence in CpG islands. CpG islands are more likely to be
found in promotor regions in mammals and their methylation tends to down regulates gene
expression (see Figure-2). That is how DNA methylation resembles a ‘jot’ before a gene ‘recipe’.

Figure 2 – Courtesy of: Mariuswalter, Wikimedia Commons, CC-BY-SA-4.0

Hypomethylation and hypermethylation of DNA are relative terms, denote less or more
methylation and can be global or local. EWAS are a common way to measure these changes. In
cancer, DNA hypomethylation often affects more of the genome than does hypermethylation, so
that the net loss or methylation is seen in many human cancers and are associated with the
overexpression of affected genes. It is worth noting that specific sites of hyper- or hypomethylation were also found connected to some types of cancers. It is likely that changes in
methylation make tissue more susceptible to cancerous changes or that they precede cancerous
genetic or histological changes in what is called Field Effect (Ehrlich, 2006) (Chai, 2009).

Histone modifications

Histones are proteins found in eukaryotic cells that pack the DNA into structural units called
nucleosomes, see Figure-3. Histones can receive several modifications such as methylation,
acetylation, phosphorylation, ubiquitination SUMOylation, citrullination, and ADP-ribosylation.
These modifications affect gene regulation and repair, chromosome condensation in mitosis and
meiosis. That is how a histone modification is like a ‘bookmark’ for a gene ‘recipe’.

Figure-3 – Histone packaging the DNA into a nucleosome.

Therefore, it is postulated that DNA methylation and histone modifications influence gene
transcriptional efficiency, will ultimately alter gene expression and influence host response.

DNA methylation in chronic periodontitis
The focus of epigenetic studies within periodontal diseases has mostly been on genes related to
inflammation or periodontal disease (Larsson, 2017). Studies have shown that methylation is

reduced in genes that are related to the immune system in the gingiva of periodontitis subjects
when compared to healthy subjects (De-Souza, 2014; Schulz, 2016).
For the study of epigenetics in periodontitis, gingival tissue had been suggested to be the
preferred tissue and is the tissue most commonly used as this is the first interface where
inflammation occurs. However, other tissues were also compared such as peripheral leukocytes,
GCF and oral epithelium (Andia, 2010) (Oliveira, 2009) (Barros, 2018) (Li, 2018).
Gingival samples may contain epithelial cells, inflammatory cells, and connective tissue cells. If
only one type of cell is of interest, laser capture microdissection can be used (Andia, 2015)
(Barros, 2014). In this method, the samples are cryopreserved, then sliced and mounted on slides
and stained. Using laser capture microdissection, the selected cells are collected for DNA
isolation. This method requires considerable resources and time and therefore is done on smaller
cohorts. Additionally, the preservation and processing are not likely to conserve sufficient
quality of RNA. The cell composition of the tissue samples can also be determined by using flow
cytometry. In this method, the cells flow through a laser beam and the reflected light is analyzed
to depict the cell type (Hernandez, 2021).
Another way to study cell composition is deconvolution techniques. Deconvolution methods use
DNA methylation as a biomarker of cell type to infer underlying cell-type proportions. Cell-type
deconvolution algorithms have two main categories: reference-based and reference-free. In the
reference-based approach, the algorithm recognizes the tissue relative cell-type composition
according to the knowledge acquired on differentially methylated regions (DMRs) specific to
cell type on the purified cell population. In the reference-free, algorithms are used when there are
no known cell-type specific DMRs (Titus, 2017).

However, most epigenetic studies of periodontitis had so far focused on specific genes. Below is
a review of the existing literature regarding each gene.
Table-1: Summary of existing literature regarding methylation in chronic periodontitis per gene
studied.

Title
Interferon gamma (IFN-g)
(Zhang, Interferon-gamma
promoter hypomethylation
and increased expression in
chronic periodontitis, 2010)
(Asa'ad, 2017)

(Viana, 2011)

Interleukin 6 (IL-6)
(Ishida, 2012)

(Stefani, 2012)

(Kobayashi, 2016)

Content
A pro-inflammatory cytokine that promotes immune cell differentiation and activation
(Fiorillo, 2018).
The promoter of INF-g in gingival epithelium tissues was found to be hypomethylated when
compared to healthy and to induced gingivitis patients. There was no statistical difference
between healthy and induced gingivitis. Transcription levels of IFN-g was highest in
periodontitis, lower in induced gingivitis, and lowest in healthy individuals
Asa’ad et al. compared methylation of IFN-g in gingival tissues of healthy individuals to
gingival tissues of periodontitis tissues at diseased sites, non-diseased sites and 2- and 8weeks post-scaling and root planning (SRP). In this study the sample size was 10 healthy and
10 disease patients. They found no statistical difference between the different groups.
In a study by Viana, gingival samples from 18 chronic periodontitis patients and 16 healthy
patients were analyzed for promotor methylation of IL-10 and IFN-g, and histomorphometric
analysis. No differences were found in the methylation frequency or numbers of
inflammatory cells in diseased versus healthy samples.
A pro-inflammatory cytokine which plays an important role in the destruction of the
periodontal ligament in periodontitis (Irwin, 1998).
IL-6 CpG site at -74 bp was found to be hypomethylated in the peripheral blood of patients
with Rheumatoid arthritis and peripheral blood of patients with chronic periodontitis in
comparison to healthy individuals. Serum levels of IL-6 were also significantly higher in
patients with hypomethylation in -74 bp site. Other CpG sites of this gene were not
methylated significantly different between the groups
In a study by Stefani et. al.,IL-6 promoter methylation, transcription levels and presence of
polymorphism -174 C/G were compared in gingival tissues from periodontitis patients and
healthy individuals. Transcriptions levels of IL-6 were higher in the periodontitis group than
the healthy. There were no differences in the presence of the polymorphism or methylation.
However, in this study only a few CpGs in IL-6 promotor were amplified -1069, -1061, 1057, -1001, -628, -610, -574, -491. There were also no differences in parameters between
periodontitis with moderate to severe periodontitis
In a study by Kobayashi, gingival and peripheral blood samples were collected from 25
chronic periodontitis patients and compared to 20 healthy individuals. They found that IL-6
promotor in gingival tissues of periodontitis patients were significantly hypomethylated
when compared to their blood samples, and that was significantly negatively correlated to

Interleukin 17C (IL-17C)
(Schulz, 2016)

Interleukin 8 (IL-8)
(Oliveira, 2009)

Interleukin 10 (IL-10)
(Viana, 2011)

Prostaglandinendoperoxide synthase -2
(PTGS2)
(Zhang, Alteration of
PTGS2 promoter
methylation in chronic
periodontitis, 2010)

probing depth. These trends were not found in the healthy group. The ratio between gingival
to blood IL-6 mRNA was significantly higher in the periodontitis group when compared to
healthy group.
IL-17 has a well-recognized role in immune surveillance at mucosal and barrier surfaces but
also has been increasingly implicated as a driver of immunopathology in settings of
autoimmunity and chronic inflammation (Abusleme, 2017).
IL-17C promoter CpG sites were found to be hypomethylated in gingival samples from
Caucasian aggressive periodontitis patients when compared to healthy individuals. It is
worth noting that in this study 20 more genes were compared and did not show significant
difference. Those genes were ATF2, CXCL14, CXCL3, CXCL5, CXCL6, FADD, GATA3,
IL10RA, IL12A, IL12B, IL13, IL13RA1, IL15, IL17RA, IL4R, IL6R, IL6ST, IL7, INHA,
and TYK2.
IL-8 is a potent chemoattractant cytokine and activator of neutrophils in inflammation.
A study by Oliviera compared IL8 promoter methylation from blood leukocytes, oral
epithelium and gingival epithelium of periodontitis patients and healthy individuals. IL8
promoter was found to be hypomethylated in oral epithelial cells in chronic periodontitis
patients and IL-8 mRNA was more abundant in gingival cells of the same group. No other
significant difference was observed.
IL-10 is an anti-inflammatory cytokine and can contribute to the maintenance of bone mass
through inhibition of osteoclastic bone resorption and regulation of osteoblastic bone
formation (Zhang, 2014).
In a study by Viana, gingival samples from 18 chronic periodontitis patients and 16 healthy
patients were analyzed for promotor methylation of IL-10 and IFN-g and histomorphometric
analysis. No differences were found in the methylation frequency or numbers of
inflammatory cells in diseased versus healthy samples
PTGS2 also called cyclooxygenase-2 (COX-2) is associated with periodontal lesion
progression (Champagne, 2003).
Zhang et al. showed hypermethylation of PTGS2 promotor in chronic periodontitis gingival
tissues and lower levels of transcriptions in chronic periodontitis when compared to gingival
tissues taken from healthy individuals. These differences were significant.

(Asa'ad, 2017)

(Loo, 2010)

Suppressor of cytokine
signaling (SOCS1 and
SOCS3)
(Andia, 2015)

Thioredoxin interacting
protein participates in the
node-like receptors (NLR)
(Barros, 2018)

Toll like receptor 2
(TLR2)
(Amormino, 2013)

Asa’ad et al., compared methylation of gingival tissues of healthy individuals to gingival
tissues of chronic periodontitis patients at diseased sites, non-diseased sites and 2 and 8
weeks post-SRP planning in previously diseased sites. They found that at base line the
periodontitis diseased samples were most methylated (13.2%), the periodontitis non-diseased
sites were less methylated (8.8%), and the healthy were least methylated (6.7%). They also
found a significant decrease in methylation in 2- and 8- weeks following treatment in the
periodontitis diseased and non-diseased groups
Loo et. al. compared DNA methylation of E-Cadherin and COX-2 in blood samples of
healthy individuals to gingival tissues obtained from chronic periodontitis patients at sites of
extraction due to stage III mobility. They found that both genes were hypermethylated in
gingival diseased tissue when compared to healthy peripheral blood.
SOCS1 and SOCS2 are inhibitors of cytokine signaling pathways and may play a role in
restraining periodontal inflammation.
In a study by Andia, gingival epithelium and connective tissue samples were obtained by
micro-dissection from 10 periodontally heathy patients and 10 periodontitis patients 3
months after treatment to control the inflammation. No differences in methylation of SOCS1
and 3 were found.
NLR family pyrin domain containing 3 inflammasome activation pathways which take part
in the activation of interleukin 1b (IL-1b) (Chen, 2009) and in another pathway thyroxineinteracting protein mediates inflammasome-generated IL-1b and insulin resistance (Zhou,
2010).
CpG site cg19693031 was found to be hypomethylated in an EWAS study comparing
peripheral blood leukocytes from 509 African American subjects with periodontitis to 400
patients of the same population without periodontitis. In this study 485,577 CpG sites were
sequenced. The results of this study are not yet published in detail.
TLR recognize conserved microbial structures, such as bacterial lipopolysaccharides and
activate signaling pathways that result in immune responses against microbial infections
(Ilango, 2016).
In a study by Amormino, gingival samples were collected from 20 chronic periodontitis
patients and compared to 20 healthy patients. TLR2 promotor was significantly
hypermethylated in the periodontitis group. The methylation significantly correlated with
higher numbers of inflammatory cells in both groups. Methylation was significantly

(Oliviera, 2011)

(Benakanakere, 2015)
Tumor Necrosis Factor a
(TNFa)
(Zhang, 2013)

(Asa'ad, 2017)
(Kojima, 2016)

(Lavu, 2019)

correlated to probing depth at the site of tissue collection but not to attachment level.
Transcription levels of TLR2 were significantly higher in the control group and were
correlated to methylation frequency only when pulling all samples. Transcription levels were
not correlated to number of inflammatory cells or any clinical measurements.
In a study by Oliviera, gingival tissues were collected from 11 chronic periodontitis patients
and 12 healthy individuals and compared the methylation levels of the promotor of TLR2
and TLR4. They found significant difference in the total methylation of the promotor of
TLR2 between disease and healthy. No significant differences were found when comparing
specific CpG sites. No differences were found in TLR4 promotor methylation or transcript.
In a study by Benakanakere, gingival samples were collected from 4 chronic periodontitis
patients to compare diseased versus healthy sites in the same patient. They showed higher
methylation frequency in the diseased sites versus the healthy sites.
TNFa was shown to participate in the pathogenesis of periodontitis. It participates in bone
metabolism, apoptosis and function of gingival fibroblasts and epithelial cells (Pan, 2019).
In a study by Zhang, gingival epithelial tissues from 17 patients with chronic periodontitis
were compared to gingival tissues from 18 healthy individuals. They also examined tissues
of 11 subjects with induced gingivitis at 3 time points. Two CpG sites in the TNFa promoter
(at -163 and -161 bp) displayed significant increased methylation. The methylation of -163
in chronic periodontitis patients was inversely associated with the transcriptional level of
TNFa. No significant difference was observed during induction or resolution of induced
gingivitis in periodontally healthy individuals.
Asa’ad et. al., compared methylation of TNFa in gingival tissues of 10 healthy individuals
to gingival tissues of 10 chronic periodontitis tissues at diseased sites, non-diseased sites and
2 and 8 weeks post-SRP. They found no statistical difference between the different groups.
In a study by Kojima et. al.,et. al.,methylation of TNFa promotor in peripheral blood was
compared between 30 healthy and 30 chronic periodontitis adult Japanese patients. In site 72 bp, there was significant hypermethylation in the chronic periodontitis patients when
compared to the healthy individuals.
In a study by Lavu et. al.,et. al.,methylation of sites -239 and -245 in TNFa promotor in
peripheral blood of 25 healthy individuals were compared to the peripheral blood of chronic
periodontitis patients. They found that from the sites that were methylated in 75-100%,
periodontitis patients had lower methylation rate.

The association between treatment of chronic periodontitis and DNA methylation was
investigated by 2 studies. The results are limited and cannot prove or deny an association
between treatment to change in DNA methylation. The only significant association is between
treatment, and reduction of methylation of COX-2 promoter 2 weeks after SRP in periodontitis
patients:
-

Andia et al. compared gingival biopsies from 10 healthy patients and 10 chronic
periodontitis patients for the differences in methylation of SOCS1, SOCS3 and LINE1.
The samples were collected 3 months following prophylaxis of both groups and SRP of
the diseased group. In the disease group, the samples were collected from sites that
showed clinical signs of inflammation at base line, and clinical signs of health at reevaluation. There were no differences in methylation of the selected genes between the
groups. This study suggests that following initial treatment, SOCS1 and SOCS2 are
comparable between healthy and chronic periodontitis patients (Andia, 2010)

-

Asa’ad et al. examined gingival biopsies of 10 healthy and 10 chronic periodontitis
patients. At base line, gingival tissues in the healthy group were collected from 3rd molar
extraction sites, and in the diseased group from normal and diseased sites. In 2- and 8weeks post SRP, samples of normal and diseased sites were again collected in the
diseased group. No significant differences were found between groups nor over time for
TNF-a and IFN-g. They did see a significant difference between methylation of COX-2
promoter in periodontitis diseased sites and healthy at base line which was almost gone at
the 2 weeks follow-up. This study suggests that SRP of periodontitis inflamed sites can
“correct” COX-2 promoter hypermethylation (Asa'ad, 2017).

A review of the literature reveals substantial variation in methodology, patient characteristics,
sample size, sample characteristics, data analysis etc. Many studies have found very limited
differences – differences that are limited to a specific gene or CpG, or differences only in a
specific way of presentation of the results. However, some studies showed more significant and
clear associations. This could be related to the small sample size, different populations,
methodology, protocol, and various types of statistical analysis. Despite the inconsistencies,
there is evidence for an association between DNA methylation of some genes and periodontal
disease risk. There is insufficient evidence to support or deny association or causality between
DNA methylation and periodontal disease or therapy. Further research is required to identify
reproducible epigenetic markers and determine the extent to which DNA methylation can be
applied as a clinical biomarker.

Materials and Methods
Study design and patient selection
The study was conducted in accordance with the Institutional Review Board (IRB) (approval
number: 821150) of the Universality of Pennsylvania, guidelines of good clinical practice and
the code of federal regulations on the protection of human subjects. Patients were periodontitis
patients scheduled to undergo periodontal-osseous surgery. Patients previously treated with nonsurgical treatment at the University of Pennsylvania Dental Medicine and were prescribed
periodontal-osseous surgery following residual periodontal pockets of ≥5 mm at 4-6 weeks
follow-up. Patients meeting the inclusion criteria were considered for the study (see table-2).

Inclusion criteria

Exclusion criteria

• Age 18+ years and in good general health.

•

Pregnant women

• Ability and willingness to follow study

•

Patients chronically treated (i.e., two weeks or

procedures and instructions.

more) with any medication known to affect
periodontal status (e.g., phenytoin, calcium

• Must have read, understood, and signed the

antagonists, cyclosporin, coumadin, and

Informed Consent.

nonsteroidal anti-inflammatory drugs).
• At least 10 teeth in the functional dentition,
excluding third molars.
• At least two quadrants with pocket depth (PD) ≥5

•

Individuals requiring prophylactic antibiotics.

•

Patients taking steroid medications except for
acute topical treatment.

mm and proximal attachment loss (CAL) 5 mm.
• The planned surgical flap should include a

•

Patients using systemic antibiotics within 3
months prior to enrollment.

healthy region i.e., Bleeding on Probing (BOP =0,
•

Presence of other known infections.

PD =2 mm, CAL =0) and a diseased site
designated for surgery (PD =5 mm, CAL =5 mm).

•

Patients who currently have, or history of
(within three months), the following diseases:
o Severe cardiovascular disease
o Severe pulmonary disease
o Severe liver disease
o End Stage Renal Disease (ESRD)
o Active malignancy
o Cerebral vascular disease
o Diabetes
o HIV, TB, hepatitis or other active infectious
disease
o Drug or alcohol abuse
o Mental or cognitive deficiencies
o Any condition which may require surgery
during the course of the study.
o Patients with bleeding or coagulation
disorders.
o History of or condition associated with
increased bleeding.
o Major surgical procedure or trauma within
30 days before the visit.

o Any condition considered by the
investigator to be exclusionary.

Table-2 – Inclusion and exclusion criteria

All patients received detailed information about the study orally and in writing and gave written
informed consent. Full medical and dental histories were recorded, and standard oral
examination was completed. Periodontal charts detailed: recessions, probing depth, attachment
level, bleeding on probing, suppuration, mobility, furcation involvement, modified gingival
index, and plaque score.

Sample size calculation
Typical studies in this dental sub-discipline use 10 to 12 subjects. We used 20 subjects. There
has been no previous study in the literature with a similar aim and design. In terms of sample
size, there is no delta to determine the actual number needed to power the study. Upon
completion of this study, the mean and standard deviation of differences in gingival
inflammation, inflammatory markers and epigenetic changes can be used to calculate the power
of a future (delta) study.

Clinical Parameters
Before the beginning of the periodontal-osseous surgery, medical history and periodontal charts
were updated by a single examiner (SNP) using UNC 1-mm prob.
Probing pocket depth (PPD) and recession of the gingival margin (REC) were recorded with
measurements rounded to the nearest millimeter at six sites of the tooth. Clinical attachment
level (CAL) was calculated as a sum of PPD and REC. Bleeding on probing (BOP) and
modified-gingival index (MGI) (Lobene, 1986) were recorded for 6 sites per tooth. Keratinized
tissue width was measured from the free gingival margins to the muco-gingival junction (MGJ)

on the direct buccal and direct lingual. Plaque index (PI) was measured using the prob on buccal
and lingual/palatal and scores were given from 0-3 according to Silness and Loe 1964 but for
every tooth and only on buccal and lingual/palatal (Silness & Loe, 1964).

Surgical Procedure and Sample Collection
The periodontal osseous surgeries were conducted by residents in the University of Pennsylvania
Periodontics residency program. During the removal of the secondary flap, the samples were
collected by a single investigator (SNP) from the otherwise discarded tissue and placed
immediately in RNA-later solution (Fisher Scientific Invitrogen RNAlater Stabilizatio Solution)
or OCT media (Fisher HealthcareTM Tissue-PlusTM O.C.T) Compound and frozen on dry ice.
Samples were later transferred to a -80° Celsius freezer.

Laboratory Processing
Up to 40 mg of tissue sample was collected in a 1.5 ml tube (DNase/RNase free) containing a
400ul cold homogenization solution. Homogenized the tissue sample in chilled 1-thioglycerol/
homogenization solution until no visible tissue fragment remains. Then split the sample volume
into two different vials (one for RNA extraction and one for DNA extraction).
Total RNA with ribosomal depletion:
I.

Isolation of RNA: Maxwell 16 LEV SimplyRNA Tissue Kit by Promega was used to
extract total RNA on the Maxwell instrument.

II.

RNA quality check: RNA concentration and purity was measured using a Nanodrop
spectrometer. The ratio of absorbance at 260 nm to absorbance at 280 nm was
checked to be within 1.8 to 2.2. The quality and quantity of the RNA were measured

using capillary (gel) electrophoresis (Bio-Analyzer/TapeStation) to produce an RNA
integrity number (RINe) between 1 to 10 (10 is the highest quality).
III.

Ribosomal RNA depletion: ribosomal RNA (rRNA) counts for most of the total RNA
in the cell. Therefore, rRNA depletion was done using RiboNaut rRNA Depletion Kit
by PerkinElmer.

IV.

Library preparation: Rapid Directional RNA-Seq Kit 2.0 by PerkinElmer and TruSeq
total RNA were used on Sciclone G3 NGSx.

V.

Quality check for library preparation: Using TapeStation.

VI.

Sequencing: sequencing of prepared libraries was done on NovaSeq. Read depth
(number of reads per sample) S1 32-40 million reads/sample. Read length (is defined
by the number of sequencing cycles) 200 cycles, paired-end (sequencing was
performed from both ends of the molecule).

DNA methylation:
I.

DNA extraction was performed on Maxwell instrument using Maxwell 16 LEV
Blood DNA Kit.

II.

Library preparation: DNA samples were prepared for sequencing using the Illumina
TruSeq Methyl Capture EPIC Library Prep kit (cat# FC-151-1003). In this protocol
the methylated sites are enhanced by Bisulfite Conversion; the unmethylated cytosine
bases in the DNA are deaminated to produce uracil bases. Methylated cytosines are
protected from the conversion, allowing for discrimination of methylated cytosine
bases by sequencing.

III.

Sequencing: sequencing of prepared libraries was done using NovaSeq. Read depth number of reads per sample S2 (55 million reads/sample). Read length (is defined by
the number of sequencing cycles) 200 cycles, paired-end sequencing was performed
from both ends of the molecule.

Data Analysis
Bulk RNA-Seq:
Samples were demultiplexed using the Illumina DRAGEN Bio-IT Platform (v3.6.3) to generate
FASTQ files. These files were then aligned on DRAGEN using the Smith-Waterman Alignment
Scoring algorithm against Homo sapiens (GRCh37.75). Gene expression quantification was also
performed on this platform using the respective gene transfer format (GTF) file. Gene counts and
mapping metrics were then generated using the Bioconductor Rsubread package within R
(v3.6.2). Differential expression was next performed using Bioconductor package, edgeR, by
means of pairwise comparisons (healthy vs. disease). Specifically, edgeR uses negative binomial
methods developed by Robinson and Smyth (2008) to determine dispersion estimates and
quantile-adjusted conditional maximum likelihood (qCML) methods to determine differential
expression between comparison groups. Differentially expressed genes were filtered by log fold
change >= 1.5 and <= -1.5 and P-value < 0.05.

MethylSeq
MethylSeq samples were also demultiplexed using the Illumina DRAGEN Bio-IT Platform.
Alignment and methylation reports were generated on DRAGEN using the Methylation Pipeline

with the Homo sapiens (GRCh37.75) reference as well. This pipeline was specified for
directional libraries which generates four types of aligned strands including: Bisulfite Watson
(BSW), reverse complement of BSW, Bisulfite Crick (BSC), and reverse complement of BSC.
Methylation reports from this pipeline were inserted into Bioconductor package, methylKit, for
differential methylation pairwise comparisons (healthy vs. disease). More specifically, this
package used Fisher’s exact test to calculate P-values which could then be adjusted to Q-values
by the Success Likelihood Index Method (SLIM). The percent of differential methylation that
must have been presented to define hyper- or hypomethylated regions was 25%.
Protein-protein interaction networks
For identified genes, the protein-protein (PPI) network was investigated using the Search Tool
for the Retrieval of Interacting Genes (STRING) database. This system imports PPI data from
published literature (Szklarczyk, 2019).
Functional analysis
Functional analysis of the most commonly overexpressed genes was analyzed using comparison
analysis in QIAGEN’s Ingenuity Pathway Analysis (IPA) software. The data was first analyzed
per sample-pair of the similarly performing genes and then combined.
Functional analysis of specific genes was done using STRING.

Results
Subjects Accountability and Baseline Characteristics
Out of 188 screened patients, twenty patients were included in the study from September 2017 to
September 2019. All recruited patients met the inclusion and exclusion criteria, were given
explanation about the study and asked to sign informed consent (University of Pennsylvania’s
IRB Protocol: 821150).
Out of the 20 subjects, 9 were females and 11 males, aged 30-68 with a median age of 49 years.
Racial distribution of the study population included 45% African American, 35% Caucasian,
15% Asians, 5% Hispanic (Table-3). This distribution of races represents the distribution in
Philadelphia County according to the U.S Census Bureau, 2013-2017 American Community
Survey 5-year Estimate (United States Census Bureau, 2018). A total of 70% of the study
population never smoked.
Population's Demographics
Gender
Female 9 (45%), male 11 (55%)
Age
Range 30-68 years of age, median 49, average 46.75
No smoking 70%, history of smoking 10%, cigarettes smoking 10%, cigars
Smoking
5%, pipe 5%
Race
African-American 45%, Caucasian 35%, Asian 15%, Hispanic 5%
Table-3: Demography of study population.
Certain study participants had medical conditions or were taking a medication that is not
considered exclusionary (Table-4).
Patient
1
3
5
6

Medical conditions
Car accident a year
ago
Hypertension,
uterine artery
embolism

Medications
Gabapentine 600 mg
Multivitamins, Citalopram (SSRI) 20 mg/day
Fe supplements
Lisinopril 20-205 mg (ACE inhibitor), Furosemide 40 mg (diuretic),
Hydrochlorothiazide 25 mg (diuretic)

8

PTSD, sleep apnea

12

Glaucoma,
emphysema, high
cholesterol
Sickle cell trait,
asthma
Heart murmur,
hypertension

13
15
19
20

-

Topomax 50 mg, Zoloft 100 mg
Depo-shot - medroxyprogesterone acetate once every 3 months as birth
control
Lumigan eye drops, Timolol meltate (beta block), Rosuvastatin (Statin)
Albuterol (bronchodialator)
Amlodipine 5 mg BID (calcium channel blocker)
Atorvastatin

Table-4: Medical history and medications of study population.

Clinical Periodontal Findings
When comparing the disease versus control sites where the tissue was collected for analysis,
there was a significant difference in CAL and PD: PD was on average 5.5 mm in disease sites vs.
2.7 mm in control sites (p<0.001), CAL in disease 5.8 mm vs. 3.1 mm in control (p>0.001)
(Table 5). BOP, GI, and mobility were all higher in the disease group but not statistically
significant. That could be attributed to the population size.
Clinical Periodontal Findings Disease Control P value Statistical analysis
Bleeding on probing %
55
5
0.458
Chi-square
Clinical attachment level
average (mm)
5.8375 3.1125
<0.001 t test, two-sided, 95% confidence.
Gingival index average
1.1775
1.15
0.745
t test, two-sided, 95% confidence.
Mobility class 1 #sites
4
3
0.581
Chi-square
Probing depth average (mm) 5.5375 2.7125
<0.001 t test, two-sided, 95% confidence.
Table-5: Summary of clinical findings in sites of tissue collection. Statistical analysis was
conducted using R Statistical Analysis software by IBM Computer Co,. NYC.

RNA and DNA extraction results
RNA concentration and purity were measured using a Nanodrop spectrophotometer
(Nanodrop8000 by ThermoFisher Scientific). The ratio of absorbance at 260nm to absorbance at
280nm was confirmed to be within 1.8 to 2.2. The quality and quantity of the RNA were
measured using capillary (gel) electrophoresis (Tapestation2200 by Bio-Analyzer/TapeStation)

to produce an RNA integrity number (RINe) between 1 to 10 (RIN of 10 is considered high
quality RNA) (Table-6).
Sample ID
1-1
1-2
2-1
2-2
3-1
3-3
4-1
4-2
5-1
5-2
6-2
6-4
7-2
7-3
8-1
8-2
9-1
9-2
10-1
10-2
12-2
12-3
13-1
13-2
14-2
14-3
15-1
15-2
16-2
16-3
17-2
17-3
18-1
18-2

volume
nano QC
260/280
260/230
Tape QC
RIN
0.035
43.36
2.02
1.92
82.2
0.035
48.51
2.12
1.85
67.9
0.035
84.96
2.18
2
84.1
0.035
282.7
2.19
2.13
264
0.035
5.42
1.32
1.15
2.8
0.035
41.38
2.06
1.91
46.7
0.035
105.6
2.14
2.01
102
0.035
125.2
2.19
2.07
115
0.035
49.67
2.12
1.89
53.1
0.035
31.14
2.11
1.82
36.2
0.035
46.62
2.14
1.9
46.4
0.035
17.06
1.96
1.68
24
0.035
61.06
2.12
2.02
73.9
0.035
89.63
2.16
2.03
95.2
0.035
80.77
2.12
1.97
85.2
0.035
84.98
2.19
2.03
83
0.035
141.5
2.21
2.11
111
0.035
83.7
2.18
2.04
73.9
0.035
14.43
1.99
1.7
14.2
0.035
1.443
4.57
0.91
0.308
0.035
73.95
2.08
1.99
76.3
0.035
11.56
1.59
1.26
9.67
0.035
100.5
2.08
1.94
96.4
0.035
58.06
2.14
1.98
61.8
0.035
26.94
2.05
1.77
30.6
0.035
37.48
2.02
1.88
36.4
0.035
62.5
2.1
2.01
57.5
0.035
48.23
2.01
1.93
41.9
0.035
107.7
2.07
2.05
111
0.035
11.57
1.97
1.36
7.67
0.035
62.44
2.05
2
71
0.035
57.4
2.1
1.88
58.4
0.035
33.79
2.05
1.91
36.9
0.035
31.66
2.17
1.86
34.2

9.2
7.6
9.7
7.6
8.2
9.2
8
8.9
9.6
8.8
8.8
8.1
8.5
8.1
8.1
8.9
9.4
9.4
7.7
3.5
7.9
7.7
9
8
6.6
6.9
8.4
9.1
7.7
6.9
6.4
7.5
9.3
5.5

19-1
0.035
63.93
2.12
1.92
73.3
8.2
19-2
0.035
14.56
1.92
1.4
12.8
9.3
20-2
0.035
2.558
1.26
0.61
4.4
0.254
20-4
0.035
44.64
2.14
1.87
49.4
8
31-1
0.035
42.83
2.09
1.85
54.3
8.4
31-2
0.035
21.13
2.03
1.72
29.4
6.7
Table-6: RNA concentration and purity as measured by Nanodrop spectrophotometer.
DNA concentration and purity were measured using Nanodrop spectrophotometer. The ratio of
absorbance at 260nm to absorbance at 280nm was confirmed to be within 1.8 to 2.2.
Sample ID
1-1
1-2
2-1
2-2
3-1
3-3
4-1
4-2
5-1
5-2
6-2
6-4
7-2
7-3
8-1
8-2
9-1
9-2
10-1
10-2
12-2
12-3
13-1
13-2
14-2
14-3
15-1
15-2

volume
nano QC
260/280
260/230
0.045
146.3
1.95
1.83
0.045
130.6
1.9
1.74
0.045
558
1.95
2.09
0.06
783.2
2.09
2.25
0.06
198.5
2.03
2.12
0.06
180.6
2.03
2.11
0.06
411.7
2.04
2.17
0.06
228.1
2.05
2.09
0.06
87.85
2
1.96
0.06
246.1
2.03
2.15
0.04
172.8
1.97
1.96
0.06
51.22
1.82
1.74
0.06
311.2
2.04
2.1
0.06
404.1
2.03
2.14
0.06
394.9
2.02
2.16
0.06
216.9
2.02
2.12
0.06
382.2
2.06
2.18
0.06
292.7
2.08
2.15
0.045
91.44
1.83
1.85
0.04
292.4
1.93
2.15
0.045
417.3
2.03
2.13
0.045
371.4
1.98
2.05
0.045
607.9
2.01
2.15
0.045
869.7
2.12
2.19
0.045
627.1
1.96
2.08
0.045
353.6
1.96
2.15
0.045
382.1
2.02
2.15
0.045
322.7
2.03
2.12

16-2
0.045
620.1
1.99
2.15
16-3
0.045
400.4
2
2.16
17-2
0.045
610.8
2.01
2.09
17-3
0.045
472.3
1.98
2.1
18-1
0.045
436.3
2.04
2.13
18-2
0.04
261.7
1.93
2.14
19-1
0.04
254.5
1.98
2.08
19-2
0.04
253.7
1.96
2.05
20-2
0.04
54.51
1.78
1.67
20-4
0.04
130.9
1.98
1.98
31-1
0.04
253.2
1.95
2.04
31-2
0.04
205
1.96
2.06
Table-7: DNA concentration and purity as measured using Nanodrop spectrophotometer.

RNA sequencing Results
Quality control: Two samples of disease sites (10-2 and 20-2) were excluded from sequencing
due to poor quality and quantity of RNA and they failed library preparation. One sample of a
healthy site (16-2) failed RNA sequencing.
Analysis: In order to check how the gene expression profile of healthy tissue differs from
diseased tissue, initially, RNAseq data were pooled into the two categories. However, bulk
RNAseq data for differentially expressed genes did not yield significant differences among
healthy sites versus diseased sites. This could be related to the vast variability between the
samples. Since each subject had both control and disease tissue, we opted for pairwise
comparison. Pairwise analysis of bulk RNAseq data within a subject for differentially expressed
genes is advantageous because it is independent of genetic heterogeneity.
In the pairwise comparison of the sequencing results, healthy samples served as a baseline for
each patient. The results for genes with a p-value <0.0.5 for each patient are presented in a
separate supplemental excel file (Appendix 1). For each comparison, log-fold-change (LFC) >1.5
and LFC<-1.5 are presented separately. LFC>1.5 is overexpression and LFC<-1.5 is

underexpression. “Hyper:Hypo” indicates both hypermethylation and hypomethylation were
present at that gene. “NULL” refers to no significant difference. The comparisons are presented
in alphabetical order of gene symbols.
In Table-8 and Table-9, colored in red are all the genes that were significantly over- and underexpressed, respectively. These tables suggest that the variability between samples is large. Few
samples had hardly any over- or under-expressed genes and some had greater differences. This
could be related to the specific sites collected or due to site proximity; Some samples might have
not been distant enough from healthy sites to diseased sites to show changes in gene expression
despite differences in clinical findings. Or this could be related to the multifactorial nature of
periodontitis and that for some subjects’ other factors such as dysbiotic microbiota may have
more effect on the disease.
For these reasons, differentially expressed genes that were common across samples were counted
and are presented in Appendix 2. The number of subjects that differentially expressed those
genes is presented in column “Samples with Gene”. No gene was differentially expressed in all
sample pairs. The greatest number of subjects that differentially expressed a specific gene was 9
for LFC>1.5, and 8 for LFC<-1.5 (Table-10).

Table-8: All samples LFC>1.5. In this table, colored in red are all the genes that were significantly over-expressed in at least 5
sample-pairs.

Table-9: All samples LFC<-1.5. In this table, colored in green are all the genes that were significantly under-expressed in at least 5
sample-pairs.

Number of Genes
Number of samples with the same
LFC>1.5
LFC<-1.5
differentially expressed genes
9
3
0
8
9
1
7
47
10
6
103
39
5
152
77
4
286
156
3
567
329
2
1260
906
1
2839
3072
Total # of DE genes
5266
4590
Table-10: Number of samples with differentially expressed genes for LFC>1.5 and LFC<-1.5.

Differentially expressed genes that had the most commonality between patients for LFC>1.5 and
LFC<-1.5 are presented as heatmaps in Figures-4A and Figure-5A, respectively.
The 5 sample-pairs that showed the most similarities in terms of common differentially
expressed genes for over-expression and under-expression are presented in Venn diagrams in
Figures 4B and 5B. Between the 5 most similarly performing over-expression samples, 151
genes were commonly overexpressed. Between the 5 most similarly performing under-expressed
samples, no genes were commonly under-expressed in all 5 samples. Therefore, the commonality
between this study’s sample-pairs is manifested more predominantly in the overexpressed genes.

4A.
4B.
Figure-4A: Heatmap of common genes with LFC>1.5. This plot represents the common
differentially expressed genes across the 7 most similarly preforming samples for positively
expressed genes (overexpression) in disease sites when compared to healthy sites.
Figure-4B: Venn diagram. This plot compares the top 5 most similarly performing sample pairs
for differentially expressed genes with overexpression. 151 genes were overexpressed in all 5
sample-pairs.

5A.
5B.
Figure-5A – Heatmap of common genes with LFC<-1.5. This plot represents the common
differentially expressed genes across the 6 most similarly preforming samples for negatively
expressed genes (under-expression) in disease sites when compared to control.
Figure-5B - Venn diagram. This plot compares the top 5 most similarly performing sample pairs
for differentially expressed genes with LFC<-1.5 (under-expression).

Thirteen out of the 20 genes that were overexpressed are coding for genes that take part in
differentiation, activation, or regulation of B- and T-cells. 5 out of the 9 genes that were under
expressed are related to keratin or cornified cells.

DNA Methylation Sequencing Results
The relative hypermethylation and hypomethylation of the genes that were commonly over
expressed among the study population are presented in Figures-6B and 6C, respectively. For
comparison, the relevant gene expression heatmap is presented in Figure-6A. Genes that were
not significantly over/under-expressed are presented in grey, and genes that were not
significantly hyper/hypo-methylated are grey. In the same pattern, the relative hypomethylation
and hypermethylation of the genes that were most commonly under-expressed in this study
population are presented in Figure-7B and 7C, with the under-expression heatmap next to them
in Figure-7A.
It is evident from Figure-6 and 7 that many of the genes that were differentially expressed in a
few sample-pairs expressed genes were hyper-methylated and hypo-methylated in the same
sample set. This is due to hyper- and hypo-methylation in different sites within the same gene. A
further site-specific analysis is required to determine the functional effect of hyper-methylation
and/or hypo-methylation in different sites of the same gene.

6A.
6B.
6C.
Figure 6A - Heatmap of common genes with LFC>1.5. This plot represents the common differentially expressed genes across all
samples for positively expressed genes (overexpression) in disease sites when compared to control sites.
Figure 6B - Heatmap of common genes which were overexpressed according to the RNA sequencing and hypomethylation according
to the DNA methylation sequencing.
Figure 6C - Heatmap of common genes which were overexpressed according to the RNA sequencing and hypermethylation according
to the DNA methylation sequencing.

7A.
7B.
7C.
Figure 7A - Heatmap of common genes with LFC<-1.5. This plot represents the common differentially expressed genes across all
samples for negatively expressed genes (under-expression) in disease sites when compared to control sites.
Figure 7B - Heatmap of common genes which were under-expressed according to the RNA sequencing and hypermethylation.
Figure 7C - Heatmap of common genes which were under-expressed according to the RNA sequencing and hypomethylated according
to the DNA methylation sequencing.

Figure-8
Figure-9
Figure-8: Venn diagram of the most commonly performing hyper-methylated genes. This plot
represents the 5 most similarly performing pair-samples for hyper-methylated genes. 8786 genes
were hypermethylated in all 5 sample-pairs.
Figure-9: Venn diagram of the most commonly performing hypo-methylated genes. This plot
represents the 5 most similarly performing pair-samples for hypo-methylated genes. 10067 genes
were hypo-methylated in all 5 sample-pairs.

As with RNA expression, some sample-pairs performed more similarly in terms of their hypoand hyper-methylation. Between the 5 most similarly performing hyper-methylated sample-pairs,
8786 genes were commonly hyper-methylated. Between the 5 most similarly performing hypomethylated sample-pairs, 10067 genes were commonly hypo-methylated in all 5 samples. It is
also worthwhile to notice that some sample-pairs performed similarly in multiple ways – samples
1,12,17 and 18 shared similar differential expression and methylation in multiple genes.

Gene Specific Results
Symbol
TIGIT
SIRPG
SCML4
PYHIN1
PTPN22

Hyper
0
2
0
1
0

Hypo
4
0
0
3
3

Hyper:hypo
2
3
7
2
2

Null
1
2
0
1
2

P2RY10
1
0
0
6
MS4A1
0
4
1
2
IKZF3
0
0
7
0
ICOS
0
5
1
1
CXCR4
1
3
0
3
CD96
0
0
7
0
CD6
0
0
7
0
CD3D
0
2
2
3
CD28
2
3
1
1
CD22
1
4
0
2
CD19
0
0
6
1
CCR4
0
1
0
6
CARD11
0
0
7
0
C16orf54
1
4
2
0
BLK
0
1
6
0
Total
9
37
63
31
%
6
26
45
22
Table-11: Total methylation changes of the most common over-expressed genes. The number of
pair-samples with hyper-methylation (“hyper”), hypo-methylation (“hypo”), both hyper- and
hypo-methylation (“hyper-hypo”), or no significant differences in methylation (“null”) for each
gene that was significantly over-expressed within the pair-samples with most commonality. In
turquois the genes that showed the strongest trends.

In the under-expressed genes with the most commonality between sample-pairs, there were very
few significant differences in the methylation pattern, therefore, the results are not shown. In the
over-expressed genes, most genes in most of the samples did not show significant differences in
methylation. When excluding these, there were 4 times more genes with total hypo-methylation
which correlated to the overexpression. Four genes in particular exhibited hypomethylation in
most sample-pairs that were similar. These were T-cell Immunoreceptor with Immunoglobulin
and ITIM domains (TIGIT), Membrane-Spanning 4 Domains, Subfamily A, Member 1
(MS4A1), Inducible T-cell Co-Stimulator (ICOS) and Cluster of Differentiation 22 (CD22). All
4 of these genes encode for B-cell or T-cell proteins.

TIGIT: TIGIT is a cell surface protein on Natural Killer cell (NK) and some T cells. It binds
with high affinity to the poliovirus receptor (PVR) which causes increased secretion of IL10 and
decreased secretion of IL12B and suppresses T-cell activation by promoting the generation of
mature immunoregulatory dendritic cells. It specifically suppresses NK cells and some T-cells
activation. TIGIT is considered a checkpoint inhibitory receptor that limits T-cells survival and
function, and therefore, is now becoming a potential target for immunotherapy (Chauvin, 2020)
(Fourcade, 2018).
TIGIT and periodontitis
No previous study was found to support the role of TIGIT in periodontitis. The role of NK in
periodontitis is also not clear (Wilensky, 2015). However, TIGIT was found to mitigate the
effect of periodontitis-associated oral bacteria to the progression of colon cancer; NK killing of
colorectal cancer is inhibited in the presence of various Fusobacterium nucleatum strains due to
the interaction between the Fap2 protein of F. nucleatum and TIGIT (Gur, 2017). The F.
nucleatum that was found in these tumors originated from the oral cavity thereby linking
periodontitis oral pathogens with the progression of cancer (Hajishengalis, 2021).
Effects of methylation on TIGIT
There are recent studies on TIGIT methylation. TIGIT takes part in activating regulatory T cells
(Treg) from activated effector T cells. In this process, it was found that increased expression of
TIGIT is associated with hypomethylation because methylation limits access of FOXP3 to its
DNA targets and FOXP3 binding at the TIGIT locus. (Zhang Y. , 2013). TIGIT was
overexpressed in peripheral blood of breast cancer and colorectal cancer which correlated to

hypomethylation only in colorectal cancer patients (Elashi, 2019). TIGIT is also overexpressed
and hypomethylated in tissues from colorectal cancer (Nair, 2018). In HIV patients, TIGIT was
found to be significantly hypomethylated in CD4 and CD8 T-cells. These changes correlated
significantly with mRNA expression and surface protein expression (Corley, 2020).

Figure-10: Schematic view of TIGIT gene. Refseq transcripts are represented in blue. In green,
single CpG island <300 bp is found close to the gene promoter (Kent, 2002).
MS4A1
This gene encodes a B-lymphocyte surface molecule (CD20) that plays a role in the
developmental regulation and differentiation of B-cells into plasma cells.
MS4A1 and periodontitis
MS4A1 gene was identified as a potential biomarker for chronic periodontitis in a pooled
microarray gene expression study. In the study, the authors pooled 3 existing databases of
transcriptomic datasets of gingival tissues with chronic periodontitis and used bioinformatic
analysis tools to find candidate genes for diagnosis and prognosis of chronic periodontitis. One
of the genes that consistently came up as a candidate for diagnosing and prognosing chronic
periodontitis was MS4A1 (Suzuki, 2019).
In a study of sequential gene expression in the gingiva during the induction and resolution of
experimental gingivitis, MS4A1 was found to be significantly over-expressed during the first
week of induced gingivitis and the first 4 days of resolution (Jonsson, 2011).

Effects of methylation on MS4A1
CD20 which is the protein translated from MS4A1 gene, is a common target of cancer targeted
treatments. It was found in cancer studies, that MS4A1 methylation was not related to CD20
expression (Pavlasova, 2020) (Tomita, 2016) but maybe in some types of cancers (Liu, 2020).
Histone acetylation was found to be responsible for CD20 downregulation following
chemotherapy with rituximab, and not DNA methylation (Sugimoto, 2009). Nonetheless, there
are no studies examining the effect of DNA methylation of CD20 and its gene expression in the
context of periodontal disease.

Figure-11: Schematic view of MS4A1 gene. Refseq transcripts are represented in blue. In green,
single CpG island is found on the gene promoter. Courtesy of the University of California Santa
Cruz (Kent, 2002).
ICOS
ICOS encodes for protein CD278. CD278 is expressed on activated CD4+ T cells, binds to ICOS
ligand on B-cells, macrophages, and dendritic cells. It is a co-stimulator for T-cell proliferation
and cytokine secretion (Maawy, 2018).
ICOS and periodontitis
Single nucleotide polymorphism in ICOS was found to be not correlated to chronic periodontitis
in a study done on the white population in Minnesota (Wohlfahrt, 2006), but was found to be
related to aggressive periodontitis in the Brazilian population (Silva, 2013). Significantly
increased expression of ICOS was found in periapical lesions (Tao, 2019).

Effects of methylation of ICOS
Methylation of ICOS was found to be significantly altered in T-cell lymphoma (Zhang Q. ,
2011), head and neck squamous cell carcinoma (De-Vos, 2020), HIV (Shiau, 2019) and breast
cancer (Dedeurwaerder, 2011).

Figure-12: Schematic view of ICOS gene. Refseq transcripts are represented in blue. In green,
no CpG island <300 bp is found on the gene promoter. Courtesy of the University of California
Santa Cruz (Kent, 2002).
CD22
CD22 is a regulatory molecule on B-cells that prevents the overactivation of the immune system
and the development of autoimmune diseases.
CD22 and periodontitis
In an immunohistochemical study of gingival tissues from patients with severe periodontitis,
there was a significant increase in CD22+ cells when compared to tissues from healthy
individuals (Seguier, 2001). A similar study showed a decrease in CD22+ cells in gingival
samples from adult periodontitis versus healthy (Gemmell, 1991).
Effects of methylation of CD22
Methylation of CD22 was significantly reduced in tissue taken from oral squamous cell
carcinoma when compared to healthy tissue taken next to the lesion. The hypomethylation did
not seem to correlate with overexpression (Basu, 2017).

Figure-13: Schematic view of CD22 gene. Refseq transcripts are represented in blue. In green,
CpG island is found after the gene. Courtesy of the University of California Santa Cruz (Kent,
2002).

Protein-protein interaction networks
The PPI network was constructed for the 4 identified genes using the Search Tool for the
Retrieval of Interacting Genes (STRING) database (https://string-db.org/).
STRING is a database of known and predicted protein-protein interactions. The interactions
include direct (physical) and indirect (functional) associations; they stem from computational
prediction, from knowledge transfer between organisms, and from interactions aggregated from
other databases.

Figure-14: STRING analysis of TIGIT. This network has 8 nodes and 10 edges. TIGIT top 5
interactions are with genes PVR, PVRL3, PRR4, PVRL2, CD226 (Szklarczyk, 2019).
Of the top 5 interactions of TIGIT, in the present study CD226 was over-expressed in 3 samplepairs.

Figure-15: STRING analysis of MS4A1. This network has 26 nodes and 51 edges. MS4A1 top 5
interactions are with genes ENSG00000259680, LCK, IGHV3-11, CSNK2A2, CSNK2A1
(Szklarczyk, 2019).
Of the top 5 interactions of MS4A1, in the present study LCK was over-expressed in 6 samplepairs.

Figure-16: STRING analysis of ICOS. This network has 26 nodes and 64 edges. ICOS top 5
interactions are with genes MFI1, B7RP1, LCP2, PIK3R1, TBK1 (Szklarczyk, 2019).
Of the top 5 interactions of ICOS, in the present study LCP2 was over-expressed in 3 samplepairs.

Figure-17: STRING analysis of CD22. This network has 26 nodes and 99 edges. CD22 top 5
interactions are with genes SYK, PLCG1, GRB2, SHC1, INPP5D (Szklarczyk, 2019).
Of the top 5 interactions of CD22, in the present study no other gene was found to be
differentially expressed or differentially methylated in the present study.

Functional Enrichment Analysis
Functional Enrichment Analysis of Commonly Performing Samples
Functional enrichment analysis was performed to identify biological functions that are enriched
in the genes that were found more than expected by chance. Individual Ingenuity Pathway
analysis (IPA) was carried out for the 29 genes that were significantly and differentially
expressed in the similarly performing sample-pairs, which are sample-pairs #1,5,12,13,14,17 and
18 (represented in heatmaps Figure-4A and 5A). Further, a comparative analysis was conducted
to create concatenated data (Figure-14).

IPA system is based on manually curated content of QIAGEN Knowledge Base. The QIAGEN
Knowledge Base uses QIAGEN ontology.

Figure-14: Comparative analysis of the canonical pathways. Comparative analysis for the 29
genes that were significantly differentially expressed in similarly performing sample-pairs.
According to this functional analysis, Th2 pathway and T-cell receptor signaling pathways were
the pathways that were mostly affected in the sample-pairs and genes included.

Functional analysis of specific genes
Functional analysis for the specific genes was done on STRING using GO-terms. The Gene
Ontology (GO) is a bioinformatics system that unifies the representation of gene and gene
products of all species. GO has a controlled vocabulary (GO-terms) of genes and genes products,
that includes a code and an annotation to allow for easy access to the existing data and enable
functional interpretation. The ontology covers 3 domains: biological process, molecular function,
and cellular component.

TIGIT
Biological Process (GO)
GO-term
Description
GO:0007157
Heterophilic cell-cell adhesion via plasma membrane cell
GO:0008037
Cell recognition
GO:0007156
Homophilic cell adhesion via plasma membrane adhesion
GO:0002860
Positive regulation of natural killer cell mediated cytotoxicity
GO:0034332
Adherens junctional organization
Molecular Function (GO)
GO-term
Description
GO:0050839
Cell adhesion molecule binding
GO:0042803
Protein homodimerization activity
GO:0001618
Virus receptor activity
GO:0005102
Signaling receptor binding
Cellular component (GO)
GO-term
Description
GO:0005912
Adherens junction
GO:0005887
Integral component of plasma membrane
GO:0009986
Cell surface
GO:0044291
Cell-cell contact zone
GO:0043296
Apical junction complex

MS4A1
Biological Process (GO)
GO-term
Description
GO:0002768
Immune response-regulating cell surface receptor signaling
GO:0050851
Antigen receptor-mediated signaling pathway
GO:0006955
Immune response
GO:0002429
Immune response-activating cell surface receptor signaling
GO:0002250
Adaptive immune response
Molecular Function (GO)

GO-term
Description
GO:0003823
Antigen binding
GO:0042609
CD4 receptor binding
GO:0042605
Peptide antigen binding
GO:0042610
CD8 receptor binding
GO:0004715
Non-membrane spanning protein tyrosine kinase activity
Cellular component (GO)
GO-term
Description
GO:0098552
Side of membrane
GO:0042613
MHC class II protein complex
GO:0071556
Integral component of lumenal side of endoplasmic
GO:0009897
External side of plasma membrane
GO:0005886
Plasma membrane

ICOS
Biological Process (GO)
GO-term
Description
GO:0002684
Positive regulation of immune system process
GO:0007259
Receptor signaling pathway via JAK-STAT
GO:1901698
Response to nitrogen compound
GO:0035556
Intracellular signal transduction
GO:0016310
Phosphorylation
Molecular Function (GO)
GO-term
Description
GO:0016773
Phosphotransferase activity, alcohol group as receptor
GO:0016301
Kinase activity
GO:0046935
1-phosphatidylinositol-3-kinase regulator activity
GO:0016740
Transferase activity
GO:0019903
Protein phosphatase binding
Cellular component (GO)
GO-term
Description
GO:0005829
Cytosol
GO:0005942
Phosphatidylinositol 3-kinase complex
GO:0005737
Cytoplasm
GO:0061695
Transferase complex, transferring phosphorus-containing group
GO:0045121
Membrane raft

CD22
Biological Process (GO)
GO-term
Description
GO:0002764
Immune response-regulating signaling pathway
GO:0002757
Immune response-activating signal transduction
GO:0002768
Immune-response-regulating cell surface receptor signaling pathway
GO:0002376
Immune system process
GO:0038095
Fc-epsilon receptor signaling pathway
Molecular Function (GO)
GO-term
Description
GO:0051219
Phosphoprotein binding
GO:0005168
Neurotrophin TRKA receptor binding
GO:0001784
Phosphotyrosine residue binding

GO:0019901
Protein kinase binding
GO:0005102
Signaling receptor binding
Cellular component (GO)
GO-term
Description
GO:0098797
Plasma membrane protein complex
GO:0005886
Plasma membrane
GO:0005911
Cell-cell junction
GO:0045121
Membrane raft
GO:0030054
Cell junction

Discussion
Most studies of methylation in chronic periodontitis studied specific gene promotors. EWAS
studies of methylation in periodontitis are scarce. To our knowledge only two other published
studies conducted genome-wide methylation analysis (De-Souza, 2014) (Hernandez, 2021):
De Souza et al. compared gingival samples from 12 chronic periodontitis patients and 11 ageand gender-matched healthy individuals. The samples included junctional epithelium and
connective tissue. The samples were analyzed using micro-array (Infium) high throughput assay
and presented as differences between disease and control total methylation scores of 3 groups of
genes– cell cycle related genes, stably expressed genes, and immune related genes. They found
that the variation in methylation is the biggest in the immune related genes when compared to
stably expressed genes and cell-cycle related genes (De-Souza, 2014). Hernandez et al.
compared the methylation of peripheral blood leukocytes from 8 chronic periodontitis patients to
8 aged- and sex-matched healthy patients. They used the Illumina MethylationEpic platform and
correlated the results to the differential cell composition as measured in cell cytometry and
deconvolution technique. They also did functional enrichment analysis of the differentially
methylated genes. They found 81 hypermethylated genes and 21 hypomethylated genes.
However only 3 genes passed the sensitivity analysis after including the proportions of NK and
B cells - Zinc finger protein 718 (ZNF718) and homeobox A4 (HOXA4) that were
hypermethylated and zinc finger protein 57 (ZFP57) that was hypomethylated (Hernandez,
2021).
The caveat of De Souza’s study includes the absence of data on specific genes and Hernandez’s
study examined leukocytes from peripheral blood. The advantages of our study in comparison to

the existing literature are: first is tissue selection - this is the first EWAS study that utilized
gingival tissues from the same subject in chronic periodontitis and healthy site. Secondly, that
the diseased and control samples are taken from the same patient are analyzed with pairwise
comparison to eliminate Mendelian genetic interference. And third, that this study looks at both
transcriptome and methylome data.

Biomarkers of periodontitis were studied in different tissues, locally and systemically
(Stathopoulou, 2015). However, the preference to study gingival samples in chronic periodontitis
methylation studies is a logical start point because this is the site of the initial insult. The
majority of methylation studies in chronic periodontitis studied gingival epithelium samples
(Zhang, 2010) (De-Souza, 2014) (Andia, 2015) (Asa'ad, 2017) (Viana, 2011) (Amormino, 2013)
(Stefani, 2012). However, in these studies, methylation in chronic periodontitis was examined
from different tissues such as peripheral blood (Lavu, 2019) (Loo, 2010) (Ishida, 2012), GCF
(Li, 2018), or oral epithelium (Baptista, 2014). None of these studies is an EWAS, and therefore
are limited to specific genes rather than the whole genome.
An interesting study done by Kobayashi (Kobayashi, 2016), compared gingival and peripheral
blood methylation of healthy and chronic periodontitis patients. They found significant
hypomethylation of IL-6 promotor in gingival tissues of periodontitis patients when compared to
the same patients’ blood samples. The hypomethylation was also in correlation with probing
depth. Therefore, this study suggests changes in methylation of the gingiva that are in correlation
to clinical status and that are not in correlation with peripheral blood methylation (Kobayashi,
2016).

The vast majority of studies compared samples from patients with chronic periodontitis to
healthy patients ignoring the fact that Mendelian genetics could play a key role in modulating
differentially expressed genes and disease outcome. Except for the present study, there was only
one instance of comparing methylation different sites of the gingiva; In a review article by
Barros et. al., the author presents a study where gingival tissues from inflamed and non-inflamed
sites in the same patient showed different methylation pattern of CpG sites (Barros, 2014).
When comparing different patients, even when matching, there is a risk that unmeasured
confounders affect the results. Table-8 and table-9 in this study’s results are a good
representation of the wide disparity between patients despite the strict exclusion criteria and
selectiveness of included sites. First, chronic periodontitis is a multifactorial disease, as
discussed broadly in the introduction, it could be that the disease in pair-samples that did not
show differences are more affected by other parameters that were not measured here. Second,
periodontitis has both localized and systemic effects and there are no clear boundaries as to
where the effect ends. The control and disease samples were collected within the same surgical
area on sites that showed different clinical signs of the disease. Since we do not know the area of
the field effect, it is plausible that some samples’ proximity was too close to show differences
(Chai, 2009).

A few studies have analyzed transcriptome and methylome together. It is important to study the
changes in transcription in conjunction with methylation to understand the effect of methylation
on the expression of a gene. Zhang and Amormino’s groups found higher methylation of PTGS2

and TLR2 respectively and lower gene expression in the chronic periodontitis group when
compared to the healthy group (Zhang, 2010; Amormino, 2013). De Souza et al. found
significantly lower methylation and higher gene expression of the immune group genes in the
chronic periodontitis when compared to healthy controls, and an inverse relationship for the cell
cycle gene group (De-Souza, 2014). Zhang et al. found lower methylation of INF-g gene and
significantly higher transcription (Zhang, 2010). Zhang et al. also found TNF-a promotor hypermethylation in CpG -163 bp which was significantly inversely associated with the gene
expression (Zhang, 2013). Stefani et al. reported no statistically significant differences in IL-6
methylation between the chronic periodontitis group and controls, but a statistically significant
difference in transcription between the groups (Stefani, 2012).
Chronic periodontitis is a multifactorial disease that is influenced by numerous innate and
environmental, localized, and systemic parameters. Methylation is another part of the puzzle. In
addition, methylation in itself is a complex mechanism, it’s effect changes between different
genes and different compositions and locations on specific sites. Since methylation is very
complex and has a relative effect in addition to many other parameters, comprehensively
understand its effect will require big data studies encompassing a large population, spanning over
time, comparing systemic to the localized tissues.

In this study, healthy individuals with chronic periodontitis undergoing osseous surgery were
recruited. The study population was varied in terms of gender age and race and represented the
population of Philadelphia. 70% were non-smokers and 50% were taking prescribed

medications. The clinical periodontal findings showed a significant difference between control
and disease sites in terms of CAL and PD (p>0.001).
Following RNA sequencing and DNA bisulfite conversion and sequencing, the samples were
analyzed via pairwise comparison (healthy sites versus diseased sites in the same patient).
The variability between samples was found to be substantial. Some samples had hardly any overor under-expressed genes and some had a lot. This could be related to the specific sites collected
– due to the site proximity of some samples that might have not been far enough from each other
to show differences in gene expression pattern despite differences in clinical findings. There is
no literature to determine the distance of the field effect at this point in time. Until such distance
is determined, this challenge will encompass any epigenetic study that compares tissues from the
same individual.
This could also be related to the multifactorial nature of periodontitis and that for some patients
other factors have more effect on the disease. It could also be related to the diverse population
recruited to the study. From the samples that had the most similarities between them
(#1,5,6,12,13,14,17,18) two were of Asian descent and the majority are of African-American
descent. The majority of samples that did not perform similarly are of Caucasians and one
Hispanic subject. This supports the theory that in certain populations periodontal disease is
affected more similarly by DNA methylation than other populations.
Racial disparities in periodontitis are well known. In a report based on the 2009-2012 National
Health and Nutrition Examination Survey (NHANES), periodontitis prevalence was highest in
Hispanics (63.5%) and non-Hispanic blacks (59.1%), followed by non-Hispanic Asian
Americans (50.0%), and lowest in non-Hispanic whites (40.8%) (Eke, Update on Prevalence of

Periodontitis in Adults in the United States: NHANES 2009 to 2012, 2015). Genetic, socioeconomic and education levels are some of the suggested explanations for this disparity.
Methylation differences among races are not well studied and are poorly understood at this time,
but some of these differences are present at birth (Adkins, 2011) and could be attributed to
epigenetic memory.
Therefore, further analyses looked at differentially expressed genes that were common across
samples. This type of analysis yielded more genes that had significant overexpression than
under-expression, and more commonalities were detected for over-expressed genes than underexpressed genes. This is in agreement with other studies and is to be expected in sites of
inflammation (Kobayashi, 2016) (Stefani, 2012) (Ishida, 2012) (Zhang, Interferon-gamma
promoter hypomethylation and increased expression in chronic periodontitis, 2010) (Zhang,
2013).
13 out of the 20 genes that were overexpressed are coding for genes that take part in
differentiation, activation, or regulation of B- and T-cells. This could be related to the chronic
nature of the disease and will be discussed later in this discussion. 5 out of the 9 genes that were
under expressed are related to keratin or cornified cells. This could be related to the fact that
inflammatory cytokines are implicated in skin barrier disruption by downregulating the protein
expression of the cornified envelop (Francois-Xavier , 2012).
In the under-expressed genes with the most commonality between sample-pairs, there were very
few significant differences in the methylation pattern. In the over-expressed genes, most genes in
most samples did not show significant differences in methylation. When excluding these, there
were 4 times more genes with total hypo-methylation which correlates to the overexpression.

Four genes, in particular, had total hypomethylation in most sample-pairs that were analyzed.
These were TIGIT, MS4A1, ICOS and CD22.
Gene
TIGIT

Role
T-cell
immunoreceptor.
Anti-inflammatory.
Cancer tx target
MS4A1 Encodes CD20 on Bcells. Proinflammatory. Cancer
tx target
ICOS
Encodes CD278 on
CD4+. Proinflammatory.

Periodontitis studies
0

1 chronic
periodontitis study. 1
induced gingivitis

Methylation studies
Hypomethylation was found to
be correlated with
overexpression in colorectal
cancer and HIV.
In some types of cancers,
MS4A1 methylation was found
to be unrelated to its
methylation
ICOS methylation is altered in
T-cell lymphoma, head and
neck squamous cell carcinoma,
breast cancer and HIV.

1 chronic
periodontitis study
(no correlation). 1
aggressive
periodontitis study (+
correlation).
CD22
B-cell
2
Reduced methylation in oral
immunoreceptor.
Increase in “severe
squamous cell carcinoma.
Prevents
periodontitis”.
overactivation.
Decrease in “adult
periodontitis”
Table-12: Summary of the genes and their function with corresponding literature.

TIGIT and CD22 are presented on T- and B-cell respectively and take part in the suppression of
inflammation. MS4A1 and ICOS are presented on B- and T-cell respectively and are proinflammatory. MS4A1 overexpression was found to be correlated to chronic periodontitis and
was suggested as a potential biomarker in a pooled microarray study (Suzuki, 2019). It was also
found to be overexpressed in induced gingivitis (Jonsson, 2011). MS4A1 methylation was
studied in lymphoma and lymphoma treatment and treatment resistance. Its part in the
lymphoma, treatment and treatment resistance appear to be very very limited (Pavlasova, 2020)
(Tomita, 2016) (Sugimoto, 2009). On the other hand, MS4A1 expression was found to correlate
to its methylation in testicular germ cell tumor and diffuse large B-cell lymphoma (Liu, 2020).

Further research is necessary to better understand the role of MS4A1 in chronic periodontitis and
the mechanism by which its methylation affects or does not affect its transcription. ICOS single
nucleotide polymorphism was found to be not related to chronic periodontitis (Wohlfahrt, 2006)
but positively related to aggressive periodontitis and periapical lesion (Silva, 2013) (Tao, 2019).
According to studies of different cancer types, the effect of methylation on ICOS expression
seems to be complex and further studies are required (Zhang Q. , 2011) (De-Vos, 2020) (Shiau,
2019) (Dedeurwaerder, 2011). TIGIT role in periodontitis was not studied before but it was
found to be activated by F. nucleatum from the oral cavity and have a repressive effect on NK
cells cytotoxicity in cancer (Gur, 2017) (Hajishengalis, 2021). TIGIT’s methylation was found to
correlate to its transcription in colorectal cancer and HIV (Elashi, 2019) (Nair, 2018) (Corley,
2020). Zhang Y et. al., suggested a mechanism for the effect of hypomethylation on
overexpression of TIGIT (Zhang Y. , 2013). Therefore, further studies could potentially reveal
interesting correlations and mechanisms, maybe even suppressive effect of TIGIT on
inflammation in chronic periodontitis. CD22+ cells were found to be increased in gingival
tissues in “severe periodontitis” and “adult periodontitis” in immunohistochemical studies in the
’90s and early 2000 (Seguier, 2001) (Gemmell, 1991). CD22 methylation was significantly
reduced in an EWAS study of tissues taken from oral squamous cell carcinoma when compared
to adjacent healthy tissue but this did not correlate to CD22 expression (Basu, 2017). Further
research is needed to understand the role of CD22 in chronic periodontitis and the effect of
methylation on its transcription.
The PPI analysis revealed that genes CD226, LCK, and LCP21 that closely interact with TIGIT,
MS4A1 and ICOS respectively are over expressed in the present study. This analysis supports
the main results of the study.

All four genes that were found in our study are related to the acquired immunity. Only MS4A1
overexpression was found to be related to chronic periodontitis in previous studies. None of the
genes’ methylation was previously studied in the context of periodontitis. Further investigation is
necessary to better understand the role of MS4A1, ICOS, TIGIT and CD22 in chronic
periodontitis and the mechanism that their methylation affects their transcription.

The functional enrichment analysis on similarly performing samples pointed to activation of the
Th2 pathway and T cell receptor signaling pathway and to a lesser degree on granulocyte
adhesion. The overactivation of T-cell related pathways in sites of disease relative to sites of
health in the same subjects in chronic periodontitis points at the importance of the cell mediated
adaptive immunity in the progression of the disease. It is also interesting that some of the genes
that were overexpressed are pro-inflammatory and some are anti-inflammatory. To understand in
depth, the interactions and pathways that lead to these processes, further research is required.

Limitations of the present study are:
- Study design - This study is a cross-sectional study and does not represent longitudinal data,
progression, or treatment data. It cannot differentiate between observed methylation patterns
related to response to disease conditions, to that could predispose to disease.
- Tissue samples - The samples represent whole epithelium, and not specific cell type, which
could be considered an advantage or a disadvantage. A disadvantage because the methylation
analysis could be influenced by the cell composition. An advantage because it gives a true

representation of functional whole tissue, while cell composition can be extrapolated or
directly measured by deconvolution or cell-cytometry, respectively.
In the future, we would like to: Conduct RNAseq deconvolution technique to account for cell
type differences, site specific methylation analysis (results represented here are for the total
methylation of each gene), comparison to induced gingivitis study (part two of existing study).

Conclusions
In this study, we found 4 candidate genes for potential biomarkers of chronic periodontitis.
MS4A1, ICOS, TIGIT and CD22 were found to be significantly overexpressed and
hypomethylated in multiple chronic periodontitis samples when compared to healthy sites taken
from the same subjects. African-American and Asian subjects tend to show similar trends in
terms of differential expression of genes and differential methylation compared to Caucasian
population.
To our knowledge, this is the first report of the EWAS study in chronic periodontitis that looked
at gingival tissues from the same patient, and the first report of the association between chronic
periodontitis to TIGIT and ICOS genes.
For clinical applications, a combination of biomarkers would likely be necessary for chronic
periodontitis diagnosis and prognosis. EWAS studies of gingival tissues transcriptome and
methylome are useful for screening to investigate biomarker candidates for chronic periodontitis.
Further validation of these biomarkers using in vivo functional studies is necessary.
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Appendices
Appendix 3
Below is the list of genes that were significantly differentially expressed in a common fashion
between the most number of pair-samples. In yellow the genes that are related to B- and T-cell
activation and proliferation for the overexpressed genes, and to keratin and cornified cells for the
under-expressed genes. In turquois the genes that were significantly over expressed and
undermethylated.
Overexpressed genes
TIGIT – T-cell immunoreceptor with immunoglobulin and ITIM domains. TIGIT is a cell
surface protein that suppresses T-cell activation. It belongs to the PVR family of
immunoglobulin (Ig) proteins.
SIRPG – single regulatory protein gamma. SIRPG is expressed on the surface of most T cells
and some B cells. It bounds to CD47, and induced apoptosis. Binding was enhanced in activated
peripheral blood mononuclear cells compared with resting cells.
SCML4 - Scm Polycomb Group Protein Like 4
PYHIN1 – Pyrin and HIN domain family, member 1. A part of a family of proteins that are
primarily nuclear and are involved in transcriptional regulation of genes important for cell cycle
control, differentiation, and apoptosis.
PTPN22 – protein tyrosine phosphatase, nonreceptor-type, 22. It affects the responsiveness of T
and B cells receptors. Mutations in the gene are associated with autoimmune diseases.
P2RY10 – purinergic receptor P2Y, G protein-coupled, 10. This gene encodes a protein that is
part of the G-protein coupled receptors.
MS4A1 – membrane-spanning 4 domains, subfamily A, member 1. This gene encodes a Blymphocyte surface molecule (CD20) that plays a role in the development and differentiation of
B-cells into plasma cells.
IKZF3 – Ikaros family zinc finger 3. It encodes transcription factor that is important in the
regulation of B lymphocyte proliferation and differentiation.
ICOS – Inducible T-cell co-stimulator. Also called CD278.
CXCR4 – chemokine, CXC motif, receptor 4. Is presented on activated T cells and plays an
important role in cell-cell signaling, immune responses and regulation of cell proliferation.
CD96 – cluster of differentiation 96. The protein may play a role in the adhesion of activated T
and NK cells to their target cells during the late phase of the immune response. It may also
function in antigen presentation.
CD6 - the gene product is important for continuation of T-cell activation.
CD3D – encodes T cell surface glycoprotein CD3 delta chain.
CD28 – is expressed on T cells and provides co-stimulatory signal for T-cell activation and
survival. T cell stimulation through CD28 in addition to the T-cell receptor (TCR) can provide a
potent signal for the production of various interleukins (IL-6 in particular).
CD22 - is a regulatory molecule on B-cells that prevents the overactivation of the immune
system and the development of autoimmune diseases.

CD19 - acts as an adaptor protein to recruit cytoplasmic signaling proteins to the membrane and
it works within the CD19/CD21 complex to decrease the threshold for B cell receptor signaling.
pathways.
CCR4 = CD194 – encodes for C-C chemokine receptor type 4.
CARD11 – caspase recruitment domain-containing protein 11. encodes a protein that acts as a
scaffold for nuclear factor kappa-B (NFKB) activity in the adaptive immune response controlling
peripheral B-cell differentiation and a variety of critical T-cell effector functions.
C16orf57 – U6 small nuclear RNA biogenesis phosphodiesterase 1.
BLK – BLK protooncogene, SRC family tyrosine kinase.
Under-expressed genes
TGM7 – Transglutaminase 7. Encodes an enzyme that stabilize protein assemblies through the
formation of gamma-glutamyl-epsilon lysine crosslinks.
SPRR2G – small proline-rich protein 2G. Encodes for a component of the cornified cell
envelope, which provides the protective barrier function of stratified squamous cells.
NMRAL2P – NmrA like redox sensor, pseudogene.
LCE3E – late cornified envelope protein 3E.
LCE3D – Precursor of the cornified envelope of the stratum corneum.
KRT76 – a keratin gene.
KPRP – keratinocyte proline-rich protein.
GSDMA – gasdermin 1- Pore forming protein in apoptosis.
ALOX12B – arachidonate 12-lipoxygenase, 12R type. The encoded protein oxygenates
arachidonic acid.
The source for the data in appendix 3 is:
Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic
Medicine, Johns Hopkins University (Baltimore, MD), 2021. World Wide Web
URL: https://omim.org/

